COVID-19 antiviral treatment should be taken for longer
1 March 2024
The currently recommended five-day course of molnupiravir, an antiviral treatment, may not be long enough to treat COVID-19, according to a new paper involving Professor Joseph Standing (Ïã¸ÛÁùºÏ²Ê Great Ormond Street Institute of Child Health).